Infections Related Central Venous Catheters (CVL)

This study has been completed.
Sponsor:
Information provided by:
National Defense Medical College, Japan
ClinicalTrials.gov Identifier:
NCT00554021
First received: November 5, 2007
Last updated: June 10, 2009
Last verified: June 2009

November 5, 2007
June 10, 2009
November 2007
February 2008   (final data collection date for primary outcome measure)
Culture of bacteria with in central venous catheter. Morbidity and mortality of a patient with multiple resistant bacteria associated with use of the catheter. [ Time Frame: four months ] [ Designated as safety issue: No ]
Culture of bacteria with in central venous catheter. Morbidity and mortality of a patient with multiple resistant bacteria associated with use of the catheter. [ Time Frame: six months ]
Complete list of historical versions of study NCT00554021 on ClinicalTrials.gov Archive Site
Not Provided
Physiological data, Laboratory data, and cultured bacterial data. Further study details can be obtained from K NISHIKAWA PhD.,Department of Traumatology and Critical Care Medicine, National Defense Medical College, Japan. (kaho@jk9.so-net.ne.jp) [ Time Frame: six months ]
Not Provided
Not Provided
 
Infections Related Central Venous Catheters
Infections Associated With the Use of Central Venous Catheters Related in Critical Care Center.

The purpose of this study is to clarify the relationship between SIRS (Systemic inflammatory response syndrome) and the infection associated with the use of central venous catheters at Critical Care center in National Defense Medical College, Japan.

The doctor would remove the inserted catheter from the patient, if the patient shows SIRS. At the same time, the tip of used catheter and blood from the patient are checked whether the pathogenic bacteria exists or not by general bacterial protocol and blood culture test on a routine application. Unfortunately, these tests not always clarified their cause of SIRS. Therefore we conduct this investigation to establish the useful protocol for pathogenic bacteria. We check the pathogenic bacteria not only tip but through the whole catheter in Central Venous Catheter using general bacterial protocol and SEM observation. Additionally, we compared that sputum, urine, skin and blood from the patient for bacteria check.

Observational
Observational Model: Cohort
Time Perspective: Prospective
Not Provided
Retention:   Samples With DNA
Description:

We will use the DNA from the only clinical isolated bacteria.

Probability Sample

Critical Care staff

SIRS
Not Provided
1
Department of Traumatology and Critical Care Medicine, National Defense Medical College
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
60
February 2008
February 2008   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • A patient has been inserted with central venous line over 24 hours.
Both
14 Years to 95 Years
No
Contact information is only displayed when the study is recruiting subjects
Japan
 
NCT00554021
NDMC-CV0001
Yes
Kahoko Nishikawa, NDMC
National Defense Medical College, Japan
Not Provided
Study Director: Kahoko NISHIKAWA, PHD National Defense Medical College
National Defense Medical College, Japan
June 2009

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP